AN
ANATOLİA TANI VE BİYOTEKNOLOJİ ÜRÜNLERİ ARAŞTIRMA GELİŞTİRME SANAYİ VE TİCARET A.Ş.
ANGEN | IS
Overview
Corporate Details
- ISIN(s):
- TREANGN00010 (+1 more)
- LEI:
- 789000SFK2PSN72IVM96
- Country:
- Türkiye
- Address:
- İSTANBUL PLAZA KASAP İSMAİL SOK.NO.10/22-23, 34722 ISTANBUL
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
Anatolia develops biotechnology products, specializing in diagnostic solutions for healthcare.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
Market Cap data is planned for a future update.
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-06-25 17:12 |
Share Issue/Capital Change
2024 Yılı Olağan Genel Kurulu Hk
|
Turkish | 1.2 MB | |
| 2025-06-25 17:12 |
Declaration of Voting Results & Voting Rights Announcements
2024 Yılı Olağan Genel Kurulu Hk
|
Turkish | 1.2 MB | |
| 2025-06-25 17:12 |
General Meeting Notice
2024 Yılı Olağan Genel Kurulu Hk
|
Turkish | 308.0 KB | |
| 2025-06-25 17:12 |
General Meeting Notice
2024 Yılı Olağan Genel Kurulu Hk
|
Turkish | 15.1 KB | |
| 2025-06-25 17:12 |
Annual Report
2024 Yılı Kar Dağıtımı Yapılmaması Kararı Hk
|
Turkish | 247.0 KB | |
| 2025-06-25 17:12 |
Notice of Dividend Amount
2024 Yılı Kar Dağıtımı Yapılmaması Kararı Hk
|
English | 28.7 KB | |
| 2025-05-30 17:30 |
Proxy Solicitation & Information Statements
Yatırım Teşvik Belgesi Tutarının Güncellenmesi Hk.
|
Turkish | 17.1 KB | |
| 2025-05-30 17:29 |
Proxy Solicitation & Information Statements
RhineGene Philippines Inc.iştirakimizin kapatılması hk.
|
Turkish | 17.5 KB | |
| 2025-05-09 17:11 |
Quarterly Report
Sorumluluk Beyanı
|
Turkish | 22.1 KB | |
| 2025-05-09 17:11 |
Registration Form
Faaliyet Raporu
|
Turkish | 845.8 KB | |
| 2025-05-09 17:11 |
Interim Report
Faaliyet Raporu
|
English | 11.1 KB | |
| 2025-05-09 17:11 |
Quarterly Report
Financial Report
|
Turkish | 2.2 MB | |
| 2025-05-09 17:11 |
Quarterly Report
Financial Report
|
English | 2.4 MB | |
| 2025-05-09 17:11 |
Annual Audited Financial Statements
Financial Report
|
English | 2.5 MB | |
| 2025-04-24 17:12 |
Proxy Solicitation & Information Statements
Bağımsız Denetim Şirketinin Seçilmesi hk
|
Turkish | 29.5 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
1NKEMIA | Spain | IKM | |
|
2cureX AB | Sweden | 2CUREX | |
|
4SC AG | Germany | VSC | |
|
Abera Bioscience AB | Sweden | ABERA | |
|
ABIONYX Pharma | France | ABNX | |
|
Abliva | Sweden | ABLI | |
|
AB Science | France | AB | |
|
Acticor Biotech | France | ALACT | |
|
Active Biotech | Sweden | ACTI | |
|
AcuCort AB | Sweden | ACUC |